
Lifestance Health (LFST) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
333.0M
Gross Profit
109.8M
32.97%
Operating Income
1.6M
0.48%
Net Income
709.0K
0.21%
EPS (Diluted)
$0.00
Balance Sheet Metrics
Total Assets
2.1B
Total Liabilities
647.6M
Shareholders Equity
1.5B
Debt to Equity
0.44
Cash Flow Metrics
Operating Cash Flow
23.3M
Free Cash Flow
-10.3M
Revenue & Profitability Trend
Lifestance Health Income Statement From 2019 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2019 |
---|---|---|---|---|---|
Revenue | 1.3B | 1.1B | 859.5M | 667.5M | 212.5M |
Cost of Goods Sold | 848.6M | 753.6M | 622.5M | 466.0M | 150.1M |
Gross Profit | 402.4M | 302.1M | 237.0M | 201.5M | 62.4M |
Gross Margin % | 32.2% | 28.6% | 27.6% | 30.2% | 29.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 363.1M | 410.8M | 378.0M | 433.7M | 41.1M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 363.1M | 410.8M | 378.0M | 433.7M | 41.1M |
Operating Income | -31.6M | -189.1M | -210.2M | -286.4M | 15.2M |
Operating Margin % | -2.5% | -17.9% | -24.5% | -42.9% | 7.2% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 26.5M | 21.2M | 19.9M | 38.9M | 5.4M |
Other Non-Operating Income | 535.0K | 3.8M | -2.6M | -7.8M | -2.0M |
Pre-tax Income | -57.6M | -206.6M | -232.7M | -333.1M | 7.9M |
Income Tax | -170.0K | -20.3M | -17.2M | -25.9M | 2.2M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 28.0% |
Net Income | -57.4M | -186.3M | -215.6M | -307.2M | 5.7M |
Net Margin % | -4.6% | -17.6% | -25.1% | -46.0% | 2.7% |
Key Metrics | |||||
EBITDA | 39.0M | -108.8M | -141.2M | -233.7M | 21.3M |
EPS (Basic) | $-0.15 | $-0.51 | $-0.61 | $-1.05 | $-0.16 |
EPS (Diluted) | $-0.15 | $-0.51 | $-0.61 | $-1.05 | $-0.16 |
Basic Shares Outstanding | 379147000 | 367457000 | 355278000 | 327523000 | 373648648 |
Diluted Shares Outstanding | 379147000 | 367457000 | 355278000 | 327523000 | 373648648 |
Income Statement Trend
Lifestance Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 154.6M | 78.8M | 108.6M | 148.0M | 18.8M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 131.8M | 125.4M | 100.9M | 76.1M | 43.7M |
Inventory | - | - | - | - | - |
Other Current Assets | 14.9M | 10.7M | 11.0M | 11.7M | 810.0K |
Total Current Assets | 312.5M | 225.7M | 233.2M | 266.5M | 76.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 148.7M | 171.5M | 200.4M | 1.0M | 2.1M |
Goodwill | 2.8B | 2.8B | 2.8B | 2.7B | 2.5B |
Intangible Assets | 190.8M | 221.1M | 263.3M | 300.4M | 332.8M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 7.7M | 10.9M | 10.8M | 3.4M | - |
Total Non-Current Assets | 1.8B | 1.9B | 1.9B | 1.7B | 1.5B |
Total Assets | 2.1B | 2.1B | 2.2B | 1.9B | 1.6B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 25.7M | 23.2M | 24.4M | 24.6M | 15.0M |
Short-term Debt | 56.7M | 46.5M | 38.8M | 1.3M | 3.7M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 542.0K | 11.9M | 18.8M | 14.8M | 11.8M |
Total Current Liabilities | 228.9M | 202.9M | 176.0M | 116.8M | 75.9M |
Non-Current Liabilities | |||||
Long-term Debt | 428.5M | 461.6M | 437.7M | 157.4M | 362.5M |
Deferred Tax Liabilities | 14.3M | 15.6M | 38.7M | 54.3M | 81.2M |
Other Non-Current Liabilities | 309.0K | 952.0K | 2.8M | 53.6M | 17.2M |
Total Non-Current Liabilities | 443.1M | 478.2M | 479.1M | 265.3M | 461.0M |
Total Liabilities | 672.0M | 681.0M | 655.1M | 382.1M | 536.9M |
Equity | |||||
Common Stock | 3.8M | 3.8M | 3.8M | 3.7M | 1.0B |
Retained Earnings | -818.3M | -760.8M | -572.6M | -357.1M | -13.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.4B | 1.4B | 1.5B | 1.5B | 1.0B |
Key Metrics | |||||
Total Debt | 485.2M | 508.1M | 476.5M | 158.7M | 366.3M |
Working Capital | 83.6M | 22.9M | 57.2M | 149.8M | 359.0K |
Balance Sheet Composition
Lifestance Health Cash Flow Statement From 2019 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2019 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -57.4M | -186.3M | -215.6M | -307.2M | 5.7M |
Depreciation & Amortization | 71.0M | 80.4M | 69.2M | 54.1M | 6.1M |
Stock-Based Compensation | 76.2M | 99.4M | 187.4M | 259.4M | 54.0K |
Working Capital Changes | -52.6M | -67.3M | -27.2M | -23.6M | -3.2M |
Operating Cash Flow | 77.0M | -50.5M | 39.2M | -30.8M | 10.8M |
Investing Activities | |||||
Capital Expenditures | -21.6M | -40.5M | -79.3M | -94.5M | -14.3M |
Acquisitions | 0 | -19.8M | -60.2M | -99.6M | -59.1M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -21.6M | -60.3M | -139.5M | -194.1M | -73.4M |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | 0 |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 287.8M | 57.8M | 257.3M | 98.8M | 55.9M |
Debt Repayment | -289.5M | -2.5M | -187.8M | -311.4M | -488.0K |
Financing Cash Flow | -9.9M | 47.4M | 47.3M | 313.9M | 48.5M |
Free Cash Flow | 85.7M | -57.4M | -26.5M | -85.1M | 2.7M |
Net Change in Cash | 45.4M | -63.4M | -53.0M | 89.0M | -14.1M |
Cash Flow Trend
Lifestance Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-37.00
Forward P/E
-32.65
Price to Book
1.47
Price to Sales
1.64
PEG Ratio
0.44
Profitability Ratios
Profit Margin
-1.23%
Operating Margin
-0.85%
Return on Equity
-1.11%
Return on Assets
0.04%
Financial Health
Current Ratio
1.48
Debt to Equity
32.18
Beta
1.13
Per Share Data
EPS (TTM)
$-0.04
Book Value per Share
$3.79
Revenue per Share
$3.44
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
lfst | 2.2B | -37.00 | 1.47 | -1.11% | -1.23% | 32.18 |
HCA Healthcare | 94.6B | 16.99 | -77.25 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.15 | 4.18 | 29.65% | 7.18% | 158.70 |
DaVita | 9.8B | 13.55 | 6.86 | 57.94% | 6.35% | 825.19 |
Ensign Group | 9.8B | 30.66 | 4.80 | 17.54% | 7.00% | 100.93 |
Chemed | 6.6B | 23.36 | 5.50 | 24.14% | 11.56% | 12.15 |
Financial data is updated regularly. All figures are in the company's reporting currency.